Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 North America Infertility Drugs Market, by End User
1.4.2 North America Infertility Drugs Market, by Distribution Channel
1.4.3 North America Infertility Drugs Market, by Drug Class
1.4.4 North America Infertility Drugs Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. North America Infertility Drugs Market by End-user
3.1 North America Women Market by Country
3.2 North America Men Market by Country
Chapter 4. North America Infertility Drugs Market by Distribution Channel
4.1 North America Hospital Pharmacy Market by Country
4.2 North America Specialty & Retail Pharmacy Market by Country
4.3 North America Online Pharmacy Market by Country
Chapter 5. North America Infertility Drugs Market by Drug Class
5.1 North America Gonadotropins Market by Country
5.2 North America Aromatase Inhibitors Market by Country
5.3 North America Selective Estrogen Receptor Modulators (SERMs) Market by Country
5.4 North America Dopamine Agonists Market by Country
5.5 North America Others Market by Country
Chapter 6. North America Infertility Drugs Market by Country
6.1 US Infertility Drugs Market
6.1.1 US Infertility Drugs Market by End-user
6.1.2 US Infertility Drugs Market by Distribution Channel
6.1.3 US Infertility Drugs Market by Drug Class
6.2 Canada Infertility Drugs Market
6.2.1 Canada Infertility Drugs Market by End-user
6.2.2 Canada Infertility Drugs Market by Distribution Channel
6.2.3 Canada Infertility Drugs Market by Drug Class
6.3 Mexico Infertility Drugs Market
6.3.1 Mexico Infertility Drugs Market by End-user
6.3.2 Mexico Infertility Drugs Market by Distribution Channel
6.3.3 Mexico Infertility Drugs Market by Drug Class
6.4 Rest of North America Infertility Drugs Market
6.4.1 Rest of North America Infertility Drugs Market by End-user
6.4.2 Rest of North America Infertility Drugs Market by Distribution Channel
6.4.3 Rest of North America Infertility Drugs Market by Drug Class
Chapter 7. Company Profiles
7.1 Abbott Laboratories
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Research & Development Expense
7.1.5 SWOT Analysis
7.2 Bayer AG
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Partnerships, Collaborations, and Agreements:
7.2.5.2 Acquisition and Mergers:
7.3 Novartis AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expense
7.4 Merck & Co., Inc.
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental and Regional Analysis
7.4.4 Research & Development Expenses
7.5 Pfizer, Inc.
7.5.1 Company Overview
7.5.2 Financial Analysis
7.5.3 Regional & Segmental Analysis
7.5.4 Research & Development Expense
7.5.5 Recent strategies and developments:
7.5.5.1 Partnerships, Collaborations, and Agreements:
7.6 Teva Pharmaceutical Industries Ltd.
7.6.1 Company Overview
7.6.2 Financial Analysis
7.6.3 Regional Analysis
7.6.4 Research & Development Expenses
7.7 Sanofi S.A.
7.7.1 Company Overview
7.7.2 Financial Analysis
7.7.3 Segmental and Regional Analysis
7.7.4 Research & Development Expense
7.8 Ferring Holdings SA
7.8.1 Company Overview
7.8.2 Financial Analysis
7.8.3 Regional Analysis
7.8.4 Research and Development Expense
7.8.5 Recent strategies and developments:
7.8.5.1 Partnerships, Collaborations, and Agreements:
7.9 Organon & Co.
7.9.1 Company Overview
7.9.2 Financial Analysis
7.9.3 Regional Analysis
7.9.4 Research & Development Expenses
7.10. Mankind Pharma Ltd.
7.10.1 Company Overview
7.10.2 Recent strategies and developments:
7.10.2.1 Product Launches and Product Expansions:
Unique Offerings 